Australian Ethical Investment Adjusts Stake in Cyclopharm

Tip Ranks
2025.01.28 03:57
portai
I'm PortAI, I can summarize articles.

Australian Ethical Investment Ltd has announced a reduction in its stake in Cyclopharm Limited, decreasing its voting power from 10.04% to 8.88% as of January 23, 2025. This change reflects a shift in their investment strategy, potentially affecting their influence over Cyclopharm's decisions. Australian Ethical Investment focuses on ethical investment solutions, catering to clients who prioritize sustainability in their investment choices. The company's current market cap is €344.2M, with a year-to-date price performance of -3.85%.

Invest with Confidence:

  • Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
  • Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.

Australian Ethical Investment Ltd ( (AU:AEF) ) just unveiled an announcement.

Australian Ethical Investment Ltd has announced a change in their substantial shareholding in Cyclopharm Limited. As of January 23, 2025, their voting power has decreased to 8.88% from a previous 10.04%, reflecting a change in their investment strategy or portfolio adjustments, which may impact their influence over Cyclopharm Limited’s decisions.

More about Australian Ethical Investment Ltd

Australian Ethical Investment Ltd is a financial services company that focuses on ethical investment solutions. They provide investment products and services that align with sustainable and ethical principles, catering to clients who prioritize ethical considerations in their investment decisions.

YTD Price Performance: -3.85%

Average Trading Volume: 60

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: €344.2M

See more insights into AEF stock on TipRanks’ Stock Analysis page.

Trending Articles:

  • ‘Buy When Others Are Fearful,’ Says Investor About AMD Stock
  • Daniel Ives Pounds the Table on Palantir Stock
  • Top Analyst Sets Expectations on Intel Stock as Earnings Approach